Skip to main content

and
  1. No Access

    Chapter

    Training von Patienten mit linksventrikulären mechanischen Herzunterstützungsystemen und nach Herztransplantation

    Patienten nach LVAD-Implantation benötigen eine intensive interdisziplinäre Betreuung und Überwachung zur Vermeidung und Behandlung von Device-spezifischen Komplikationen. In den ersten Monaten nach Implantati...

    Prima. Dr. Christiane Marko, Ass.-Prof. DI Dr. Francesco Moscato in Sportkardiologie (2015)

  2. No Access

    Chapter and Conference Paper

    Patients Undergoing ICD Implantation: How Many Need Biventricular Pacing?

    The goal of ICD therapy is to prevent premature sudden cardiac death (SCD) in patients who would otherwise have a long-term survival expectancy. The major challenge is to detect the greatest number of patients...

    G. Gasparini, F. Di Pede, A. Bonso, S. Themistoclakis, R. Giada in Cardiac Arrhythmias 2001 (2002)

  3. No Access

    Chapter and Conference Paper

    Ventricular Resynchronization: What May We Expect from Technological Advances?

    Cardiac resynchronization therapy (CRT) with biventricular pacing has been recently explored as an adjunctive support to drugs to treat symptoms in patients with advanced heart failure (HF) (NYHA class III-IV)...

    M. Lunati, G. Magenta, G. Cattafi, R. Vecchi, M. Paolucci in Cardiac Arrhythmias 2001 (2002)

  4. No Access

    Chapter and Conference Paper

    Hemodynamic Sensors: What Clinical Value Do They Have in Chronotropic Incompetence?

    The physiological capacity to regulate heart rate according to changing metabolic needs is impaired to a various degree in all clinical forms of sick sinus syndrome (SSS), as well as in the presence of patholo...

    M. G. Bongiorni, E. Soldati, G. Arena, F. Di Gregorio in Cardiac Arrhythmias 2001 (2002)

  5. No Access

    Chapter and Conference Paper

    Hemodynamic Sensors: What Clinical Value Do They Have in Heart Failure?

    Up to recent years, electrical pacing has mainly been intended as a therapeutic tool in the treatment of cardiac rhythm disorders due to either atrial disorders or atrioventricular conduction defects. In order...

    M. Gasparini, A. Curnis, M. Mantica, G. Mascioli, P. Galimberti in Cardiac Arrhythmias 2001 (2002)

  6. No Access

    Chapter and Conference Paper

    Does Atrial Resynchronization Confer Further Benefit on Patients Undergoing Ventricular Resynchronization Therapy?

    Congestive heart failure is considered to be one of the most important public health problems in cardiovascular medicine. In the United States, more than 3 million people are afflicted by the disease, with nea...

    F. Di Pede, G. Gasparini, G. Zuin, A. Rossillo, A. Raviele in Cardiac Arrhythmias 2001 (2002)

  7. No Access

    Chapter and Conference Paper

    The “Pill in the Pocket” Approach for Paroxysmal Atrial Fibrillation: How Effective and Safe Is It?

    The occurrence of paroxysmal atrial fibrillation (AFib) is frequently associated with symptoms mainly due to the fast ventricular rate. In patients with nonva-lvular AFib therapy is based on drugs which slow t...

    M. Di Biase, R. Ieva, G. Mavilio, D. Casella, G. Maulucci in Cardiac Arrhythmias 2001 (2002)

  8. No Access

    Chapter and Conference Paper

    Antiplatelet Agents for Prevention of Thromboembolism in Atrial Fibrillation: When, Why, and Which One?

    Atrial fibrillation (AF) carries a high risk of systemic embolism, in particular stroke. This is true not only when AF is associated with valvular heart disease, but also in patients with nonvalvular AF, which...

    G. Di Pasquale, E. Cerè, S. Biancoli, B. Sassone, A. Lombardi in Cardiac Arrhythmias 2001 (2002)

  9. No Access

    Chapter and Conference Paper

    Blutdruckvariabilität bei Sportlern

    Blutdruckvariabilität ist Scit langem Gegenstand intensiver Studien (9, 13), obwohl ihre klinische Bedeutung bislang noch nicht vollständig definiert werden konnte (8, 11). Es wurde gezeigt, daß physische Akti...

    P. Palatini, L. Mos, P. Mormino, A. Di Marco in Indirekte 24-Stunden Blutdruckmessung (1988)

  10. No Access

    Chapter and Conference Paper

    Wirkungen einer einmaligen intravenösen Dosis von Nicergolin auf hämorheologische und hämodynamische Parameter bei peripheren Gefäßerkrankungen

    Periphere obliterierende arterielle Erkrankungen (im weiteren Text als POAD—peripheral obliterative disease —abgekürzt) sind pathophysiologisch durch eine Reduktion der nutritiven Durchblutung gekennzeichnet, ...

    T. Di Perri, M. Guerrini, R. Cappelli in Therapeutische Wirksamkeitsnachweise bei n… (1985)